trending Market Intelligence /marketintelligence/en/news-insights/trending/K9cSKAwiTBhfWBwm0_9b1w2 content esgSubNav
In This List

Gene sequencing giant Illumina cuts 58 jobs

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Gene sequencing giant Illumina cuts 58 jobs

Illumina Inc. laid off 58 employees including technical writers, scientists and engineers across its California offices, CNBC reported.

The San Diego-based gene sequencing giant fired 16 employees from its San Mateo office and 42 employees from the San Diego one in September, California's Employment Development Department report said.

The layoffs follow Illumina's lower second-quarter revenue, caused partly due to a delay in its $1.2 billion acquisition of Pacific Biosciences of California Inc.

A private direct marketing retail company, Helix Opco LLC, backed by Illumina, also laid off an undisclosed number of employees and closed several offices in May, genomics-centric news platform GenomeWeb reported.